Jump to navigation
The NCCN Annual Conference attracts more than 1,500 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.
These activities are designed to meet the educational needs of medical, surgical, and radiation oncologists; nurses; physician assistants; pharmacists; pathologists; and other healthcare professionals who manage patients with cancer.
These activities are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits may also be provided. Please refer to the complete accreditation information provided before the individual educational activity for more details.
These activities are supported by educational grants from AstraZeneca; BTG; Celgene Corporation; Clovis Oncology; Genentech; Genomic Health, Inc.; Gilead Sciences, Medical Affairs; Lilly; Merrimack Pharmaceuticals, Inc.; Novartis Oncology; Pfizer; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Taiho Oncology; Takeda Oncology; and TESARO. These activities are supported by educational funding provided by Amgen. These activities are supported by an independent medical education grant from Bristol-Myers Squibb. These activities are supported by independent educational grants from AbbVie; Astellas and Medivation, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte; and Merck.